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ABSTRACT
Objectives: Oral and oropharyngeal cancer remains among the top ten most common malignancies in the United States 
and worldwide. Over the last several decades the approach to treatment of oral cancer has changed very little with regards 
to primary tumour extirpation while the approach to the “at risk” lymph nodes has evolved significantly. Perhaps the most 
significant change in the surgical treatment of cancer is the introduction of free flap for reconstruction post resection. Despite 
these surgical advances, oral cancer ablation, still results in the sacrifice of several functional and aesthetic organs. The aim of 
this article was to provide a comprehensive review of the potential long-term complications associated with surgical treatment 
of oral cancer and their management.
Material and Methods: The available English language literature relevant to long-term surgical complications associated 
with surgical treatment of oral cancer was reviewed. The potential common as well as rarer complications that may be 
encountered and their treatment are summarized.
Results: In total 50 literature sources were obtained and reviewed. The topics covered in the first part of this review series 
include ablative surgery complications, issues with speech, swallowing and chewing and neurologic dysfunction.
Conclusions:  The  early  complications  associated  with  oncologic  surgery  for  oral  cancer  are  similar  to  other  surgical 
procedures. The potential long-term complications however are quite challenging for the oncologic team and the patient who 
survives oral cancer, primarily due to the highly specialized regional tissues involved in the surgical field.
Keywords: oral cancer; oropharyngeal cancer; postoperative complications; neurologic dysfunction; speech disorders; 
swallowing disorders.
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ABSTRACT
Objectives: To evaluate the efficacy of locally delivered doxycycline as an adjunct to non-surgical treatment with the use of 
an ultrasonic device compared to scaling and root planing using hand instruments, by means of clinical and microbiological 
criteria.
Material and Methods: Thirty three patients with chronic periodontitis participated in this cohort study and were divided 
into two groups. Patients in control group received scaling and root planing using hand instruments, whereas patients in 
control group received ultrasonic debridement and 8.8% doxycycline gel was applied after initial therapy and at 3 months at 
preselected sites. Clinical recordings concerning probing pocket depth, clinical attachment level, plaque index and gingival 
bleeding index were performed at baseline, 3 and 6 months after baseline. Subgingival samples were analysed using the 
“checkerboard” DNA-DNA hybridisation technique for Porphyromonas gingivalis, Tannerella forsythia and Treponema 
denticola.
Results: Both treatments resulted in significant improvement in all clinical recordings. Six months after the treatment a 
statistically significant decrease was observed for Porphyromonas gingivalis in both of groups and Treponema denticola in 
the control group (P < 0.05). No inter-group differences were observed (P < 0.05).
Conclusions: Both treatment modalities provided comparable clinical and microbiological results in the treatment of chronic 
periodontitis.
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INTRODUCTION
Periodontal diseases (PDs) constitute a series of 
infections caused by the microorganisms that colonize 
sites at or below the gingival margin. These infections 
commonly lead to periodontal inflammation and often 
result in the destruction of the supportive periodontal 
tissues. The organisms that cause these diseases reside 
in unique structures termed biofilms that offer partial 
protection to the colonizing organisms from the 
defense mechanisms of the host, as well as from the 
antimicrobials used for treatment [1]. The primary goal 
of conventional periodontal therapy is the alteration of 
subgingival biofilms present on periodontally diseased 
sites that could be associated with the progressive 
destruction of the supportive periodontal tissues [2]. 
It is well documented that mechanical therapy 
combined with oral hygiene instruction is effective in 
achieving this goal [3,4]. Comparisons between manual 
and power-driven approaches to plaque and calculus 
removal and their effects on clinical outcomes show 
that both are equally effective [5,6].
Over the last 3 decades, locally delivered, anti-infective 
pharmacological agents have been employed in 
attempts to treat local bacterial infections associated 
with gingivitis and periodontitis. Techniques of the local 
anti-infective therapy with pharmacological agents have 
varied widely, both in the methods of drug delivery and 
in the pharmacological agents employed. Drug delivery 
methods initially included oral rinses, then irrigation 
devices, followed by subgingival irrigation using 
syringes or powered irrigation devices. More recently, 
drug delivery has involved the incorporation of anti-
infective drugs in sustained-release vehicles enabling 
subgingival administration of the drug. These sustained-
release vehicles overcome many of the problems 
inherent in other drug delivery methods, such as rinsing 
or irrigation [7]. These systems exhibit shortcomings 
including  inadequate  or  unpredictable  penetration  of 
the periodontal pocket by the drug, rapid clearance 
of  the  drug  from  the  pocket  resulting  in  inadequate 
time of the exposure of subgingival bacteria to the 
drug and poor patient compliance [8,9]. Local anti-
infective therapy has also employed an eclectic variety 
of pharmacological agents from topical antiseptics 
to broad-spectrum antimicrobials. Chlorhexidine, 
tetracycline, minocycline, metronidazole, doxycycline, 
as well as other antimicrobials and antiseptics have 
been  used  in  several  forms. Two  systematic  reviews 
with the meta-analysis of data [7,10] from studies 
evaluating the effect of locally delivered antimicrobials 
as an adjunctive therapy to scaling and root planing 
(SRP) revealed evidence of improved clinical outcomes 
in terms of the greater PD reduction and/or clinical 
attachment  gain  compared  to  SRP  alone.  This  was 
particularly true with the use of tetracyclines, although 
the clinical significance remains questionable.
The aim of the present study was to compare the clinical 
and microbiological effects of scaling and root planing 
with hand instruments to a non-surgical treatment with 
the use of an ultrasonic device combined with the 
application of locally delivered doxycycline.
MATERIAL AND METHODS
The subjects for the present cohort study were recruited 
from the Postgraduate Clinic of the Department of 
Preventive Dentistry, Periodontology and Implant 
Biology, School of Dentistry, Aristotle University of 
Thessaloniki,  Greece  between  September  2004  and 
March  2005.  The  Ethical  Committee  of  the  School 
of  Dentistry  of Aristotle  University  of  Thessaloniki, 
Greece approved the study protocol and all participating 
patients signed an informed consent at the beginning of 
the study.
The  patients  (n  =  20)  comprising  the  control  group 
were the same as in our previous study [11]. Another 
twenty adult patients with generalised advanced 
chronic periodontitis [12] were recruited for the study 
following a screening examination of 28 patients by 
one examiner (I.V.), which included full mouth probing 
and radiographic examination, in order to comprise the 
control group. The inclusion and exclusion criteria were 
as follows:
Inclusion criteria
(i)  Subjects must be adults between 18 and 70 years 
of age.
(ii) Subjects must have at least 4 sites with initial 
probing  pocket  depth  (PPD)  ≥  5  mm  in  at  least  2 
quadrants, demonstrating bleeding on probing.
(iii) Subjects must not have received any periodontal 
treatment during the previous 6 months.
Exclusion criteria
(i)  Compromised medical condition.
(ii) Systemic antibiotics during treatment or for the last 
3 months.
(iii) Ongoing drug therapy that might affect periodontal 
therapy.
(iv) History of allergy to doxycycline hyclate or other 
tetracyclines.
(v) Requirement for prophylactic antibiotic cover of 
the patient.
(vi) Use of the chlorexidine mouthwash or any other 
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(vii) Female patients must not be pregnant or lactating. 
 
Clinical examinations were performed at the screening 
examination, 3 and 6 months after treatment and 
involved assessment of PPD, clinical attachment 
level (CAL), gingival bleeding index (GBI) [13] and 
plaque index [14]. The measurements of PPD and CAL 
were performed at six sites per tooth with a manual 
periodontal probe (Hu-Friedy PCP-UNC 15, Hu-Friedy, 
Chicago, IL, USA) to the nearest millimetre. Prior to the 
study, the intra-examiner variability test was carried out 
to assess the accuracy of examiner’s measurements. In 
order to assure the reproducibility of measurements, all 
recordings regarding PPD and CAL were repeated after 
a period of 30 minutes. In the event of a difference of 
> 2 mm between the two measurements, a third 
measurement was performed at the respective site. 
The mean of pair of the two closer measurements was 
evaluated for further analysis.
The  patients  fulfilling  the  necessary  prerequisites 
were assigned into 2 groups of 20 patients each:   
control group (scaling and root planing with hand 
instruments - SRP) and experimental group (ultrasonic 
debridement + doxycycline - UD + DOXY). At all 
time points, the outcomes of research were assessed 
blind and the examiner (I.V.) was unaware of the kind 
of treatment the patient was receiving. The analysis of 
subgingival samples was performed by three of authors 
(I.I., N.D., K.P.) who were also unaware of the treatment 
that the patient had received (coded samples).
Experimental design and treatment procedures
At the screening examination, a full mouth 
measurements of clinical parameters were recorded 
and intraoral radiographs were taken. After a period 
of 1 week (baseline examination), subgingival plaque 
samples were taken from 6 preselected sites from each 
patient. The sites were selected according to their initial 
probing depth and were divided in 3 categories: (i) 2 
sites with PPD ≤ 4 mm (shallow pockets), (ii) 2 sites 
with PPD > 4 to ≤ 6 mm (moderate pockets) and (iii) 
2 sites with PPD > 6 mm (deep pockets). No furcation, 
endo-periodontic defects or third molars were included 
in the study material. Microbiological sampling at the 
same sites, as at the baseline examination, and a full 
mouth clinical recordings were repeated at 3 and 6 
months after the baseline.
At the same session, supragingival scaling was 
performed with hand instruments and ultrasonics, 
and oral hygiene instructions (OHI) were given by 
the  examiner.  The  OHI  included  twice-daily  tooth 
brushing, using the modified Bass technique, and once-
daily inter-dental cleaning with inter-dental brushes. 
At the next appointment, two weeks after the baseline 
examination, the allocated intervention was initiated.
The treatment procedures in the control group were the 
same as described elsewhere [11]. Hand instrumentation 
of the whole dentition was performed at weekly intervals 
in three to four sessions by using Gracey Curettes under 
the local anaesthesia (SG 3/4, 11/12, 13/14 and After 
Five Curettes SAS 3/4, 11/12, 13/14, Hu-Friedy PCP-
UNC 15, Hu-Friedy, Chicago, IL, USA).
Patients of the experimental group received 
debridement of whole dentition in 3 - 4 sessions, under 
the local anaesthesia, at weekly intervals, utilizing a 
piezoelectric ultrasonic device (EMS Piezon®, EMS, 
Nyon, Switzerland) with A and P instruments (Swiss 
InstrumentsPM, EMS, Nyon, Switzerland) under water 
irrigation. The tips were examined after every session 
and  were  discarded  when  worn  out.  The  teeth  were 
treated until a smooth, appropriately debrided surface 
was achieved. In the four deeper, preselected pockets 
8.8% doxycycline gel (AtridoxTM, Atrix Laboratories, 
Inc., Ft. Collins, CO, USA) was applied at the 
completion of therapy and after the first re-examination 
at 3 months. 
In both groups the endpoint of the smoothness was 
judged by the supervisor (I.V.), who decided upon 
the completion of root instrumentation by using a 
periodontal probe (Hu-Friedy PCP 11, Hu-Friedy, 
Chicago, IL, USA) and an explorer (Hu-Friedy Wilkins-
Tufts 17/23, Hu-Friedy, Chicago, IL, USA).
Test drug
The  doxycycline  gel  (AtridoxTM, Atrix Laboratories, 
Inc., Ft. Collins, CO, USA) is a subgingival controlled-
release product composed of a two syringe mixing 
system. Syringe A contains 450 mg of the ATRIGEL® 
Delivery system, which is a bioabsorbable, low 
viscosity polymeric formulation composed of 36.7% 
poly(DL-lactide) (PLA) dissolved in a biocompatible 
carrier of 63.3% N-methyl-2-pyrrolidone (NMP). 
Syringe B contains doxycycline hyclate, which 
is  equivalent  to  44  mg  doxycycline.  The  product, 
when  mixed,  is  a  pale  yellow,  viscous  liquid  with 
a  concentration  of  8.8%  doxycycline  hyclate.  The 
two syringes are coupled together mixing the two 
components for 100 cycles. By the use of 23-gauge 
cannula attached to the delivery system the test product 
was slowly introduced into the periodontal pocket, 
starting from the base of pocket, until it reached the 
gingival margin. Following withdrawal of the cannula 
tip,  a  curette  was  used  to  pack  any  overflow  of  the 
drug down into the pocket. No periodontal dressing or 
adhesive was used. Upon contact with the crevicular 
fluid, the liquid product solidifies and then allows for http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm  J Oral Maxillofac Res 2010 (Oct-Dec) | vol. 1 | No 4 | e1 | p.4
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controlled release of drug for a period of 7 days. The 
patients were instructed not to perform oral hygiene 
measures at the treated areas for 1 week.
Microbiological evaluation
After the isolation with cotton rolls, drying and removal 
of supragingival plaque, the subgingival samples were 
taken with a sterile Gracey curette (Hu-Friedy, Chicago, 
IL,  USA),  were  subsequently  placed  individually  in 
200 μl of TE buffer (Tris HCl 10 mM, EDTA 1 mM, 
pH = 7.5) and stored after the treatment with an alkali 
solution (0.5 M NaOH) at - 4 oC.
The microbiological samples were evaluated separately 
for 3 bacterial species using the “checkerboard” 
DNA-DNA  hybridisation  technique  as  described  by 
Socransky et al. [15]. The subgingival species used for 
development of digoxigenin-labelled whole genomic 
probes were Porphyromonas gingivalis (FDC 381), 
Tannerella forsythia (FDC 338) and Treponema 
denticola (TD1).
Data analysis
CAL was set as the primary outcome variable. PPD, 
GBI and plaque index were considered as secondary 
outcomes. The data were analysed using the patient as a 
unit. The primary analysis was “per protocol” [16] and 
included all patients who attended the final examination. 
Data were entered into an Excel sheet database 
(MS  Office  Excel  2000;  Microsoft  Corporation, 
Redmond, WA, USA). Mean and standard error of 
the mean (SEM) were calculated for every parameter. 
Levene’s  test  for  the  quality  of  error  variance  was 
applied in order to check the homogeneity of clinical 
parameters at the baseline. The analysis was made for 
plaque index, GBI, PPD and CAL based on full mouth 
measurements (the third molars were not included). A 
further analysis was performed for PPD and CAL for 
the three different categories, according to the initial 
pocket depth. The first category comprised pockets with 
initial pocket depth lesser or equal to 4 mm, the second 
pockets with initial pocket depth > 4 to ≤ 6 mm and the 
third pockets with pocket depth greater than 6 mm.
Bacterial  species  were  quantified  following  the 
formation of reference curve, which allowed the 
conversion of chemiluscent signals to total bacterial 
counts (Total LabTM v2005, Nonlinear Dynamics Ltd, 
Newcastle upon Tyne, UK). The homogeneity of two 
groups at the baseline for microbiological parameters 
was checked using the Mann-Whitney test. Averaged 
bacterial scores from each subject were averaged for 
each group and compared at all time-points. A further 
comparison at the three examinations was made for 
Table  1.  Epidemiological characteristics of the patient sample 
(Mean ± SEM, per protocol analysis)
Patient groups
Control Experimental
N 16 17
Age (years) 49.62 ± 2.07 52.9 ± 2.12
Gender (male/female [%]) 50/50 41.2/58.8
Smokers  50% 42.2%
Initial PPD (mm) 3.91 ± 0.21 4.09 ± 0.18
Initial CAL (mm) 5.37 ± 0.42 5.24 ± 1.44
PPD = probing pocket depth; CAL = clinical attachment level.
the sites with initial PPD > 4 mm (moderate and deep 
pockets), which were those that received the drug in the 
control group.
The  differences  over  time  within  groups  for  both 
clinical and microbiological results were analysed with 
the non-parametric test Wilcoxon Signed Ranks. The 
comparison between control and control group was 
performed using the Mann-Whitney test. The level of 
significance was set at P < 0.05. All statistical analysis 
was carried out with the aid of statistical software (SPSS 
version 12.0, SPSS Inc., Chicago, IL, USA).
RESULTS
At the baseline examination 40 patients entered the study 
(20 in the SRP group, 20 in the UD + DOXY group), 
from which 33 subjects completed the 6 month protocol 
(16 in the SRP group, 17 in the UD + DOXY group, 
mean age 50.46, range 37 - 69 years). Four patients 
did not return for any re-examination, while another 
three did not attend the final examination. One patient 
moved, three patients started work, preventing visits to 
the clinic and the other three were unwilling to finish 
the study for personal reasons. The flowchart of the 
patients is illustrated in Figure 1 and the characteristics 
of the patient sample that completed the study are 
summarised in Table 1. The initial statistical analysis 
revealed no statistical differences between the two 
groups at the baseline examination. The intra-examiner 
variability test demonstrated that the reproducibility of 
the measurements of PPD and CAL within ± 1 mm was 
90%. No adverse effects were reported by any of the 
patients.
An average of 69.1% of all pockets in the SRP group 
and 71.5% in the UD + DOXY group had initially 
PPD ≤ 4 mm. The moderate pockets comprised 23% 
and 21.4% of all pockets respectively. The deep pockets 
were 7.9% and 7.1% respectively. At the 6 month http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm  J Oral Maxillofac Res 2010 (Oct-Dec) | vol. 1 | No 4 | e1 | p.5
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Figure 1. Flowchart of the patients throughout the study.
Enrollment
40 patients
Allocation
Follow-Up
3 months after 
baseline
Follow-Up
6 months after 
baseline
Control group
(scaling and root planing)
Allocated to intervention (n = 20)
Received allocated intervention (n = 20)
Lost to follow-up (n = 3)
1 patient started to work, 2 for 
personal reasons
Lost to follow-up (n = 1)
The patient moved
Analysed (n = 16) Analysis (n = 33)
Experimental group
(ultrasonic debridement + doxycycline)
Allocated to intervention (n = 20)
Received allocated intervention (n = 20)
Lost to follow-up (n = 1)
Started to work
Lost to follow-up (n = 2)
1 patient started to work, 1 for 
personal reasons
Analysed (n = 17)
Table 2. Mean Plaque Index and Gingival Bleeding Index scores (Mean ± SEM [mm]) at different 
examination intervals for control and experimental group patients
Baseline 3 months 6 months
Plaque Index
Control group 0.88 ± 0.03 0.26 ± 0.06a 0.26 ± 0.05a
Experimental group 0.81 ± 0.06 0.35 ± 0.03a  0.37 ± 0.04a 
Gingival Bleeding Index
Control group 0.59 ± 0.05 0.32 ± 0.04a 0.33 ± 0.05a 
Experimental group 0.61 ± 0.05 0.26 ± 0.04a  0.32 ± 0.04a 
aStatistically significant difference from baseline (Wilcoxon Signed Ranks test, P < 0.05).
examination in the SRP group the shallow pockets 
represented 84.9%, the moderate pockets 11.3% and 
the deep pockets only 3.8% of all pockets. In the   
UD + DOXY group the corresponding percentages 
were 84.2%, 12.4% and 3.4%.
Plaque index
The oral hygiene status, as assessed by the plaque index, 
during the course of study is shown in Table 2. At the 
baseline the mean full-mouth plaque scores were 88% 
in the SRP group and 81% in the UD + DOXY group. 
A statistically significant decrease to 26% in the control 
group and to 37% in the control group was recorded at 
the 6 month examination (Wilcoxon Signed Ranks test, 
P  <  0.05).  No  statistically  significant  differences 
were observed between the two groups at any 
interval (Mann-Whitney test, P > 0.05).
Gingival Bleeding Index (GBI)
A statistically significant reduction in GBI scores was 
observed in both treatment groups following treatment. 
GBI  indices  also  the  improved  following  a  similar 
pattern in both groups; at the 6 month re-examination 
the GBI was reduced from 59% to 33% in the SRP 
group and from 61% to 32% in the UD + DOXY group 
(Wilcoxon Signed Ranks test, P < 0.05, Table 2). No 
statistically significant difference in GBI between the 
two groups was observed at any examination interval 
(Mann-Whitney test, P > 0.05).
Probing Pocket Depth (PPD) 
Changes in the PPD are presented in Table 3. A marked 
mean PPD reduction was observed for both 
treatment modalities at the 3 month re-examination http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm  J Oral Maxillofac Res 2010 (Oct-Dec) | vol. 1 | No 4 | e1 | p.6
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Table 3. Probing pocket depth (PPD) scores for the various PPD categories at different examination 
intervals for control and experimental group patients
Probing pocket depth (Mean ± SEM [mm])
PPD category/patient groups Baseline  3 months  6 months 
Shallow (≤ 4 mm)
Controlc 2.90 ± 0.10 2.50 ± 0.08a 2.57 ± 0.14a
Experimental 2.76 ± 0.09 2.51± 0.06a 2.63 ± 0.07b
Moderate (> 4 to ≤ 6 mm)
Control 5.39 ± 0.05 3.84 ± 0.11a 3.86 ± 0.20a
Experimental 5.33 ± 0.04 4.11 ± 0.10a 4.11 ± 0.14a
Deep (> 6 mm)
Control 7.88 ± 0.23 5.17 ± 0.20a 4.74 ± 0.31a
Experimental 7.77 ± 0.15 5.94 ± 0.20a 5.61 ± 0.14a,b
Overall
Control 3.91 ± 0.21 3.03 ± 0.13a 3.03 ± 0.19a
Experimental 4.09 ± 0.19 3.15 ± 0.11a 3.17 ± 0.12a
aStatistically significant difference from baseline (Wilcoxon Signed Ranks test, P < 0.05).
bStatistically significant difference from 3 months (Wilcoxon Signed Ranks test, P < 0.05).
cNo statistically significant differences were observed between groups (Mann-Whitney test, P > 0.05).
Table 4. Clinical Attachment Level scores for the various probing pocket depth categories at different 
examination intervals for control and experimental group patients
Clinical Attachment Level (Mean ± SEM [mm])
PPD category/Patients groups Baseline 3 months  6 months
Shallow (≤ 4 mm)
Controlb 4.45 ± 0.35 4.41 ± 0.35 4.36 ± 0.36
Experimental 3.97 ± 0.26 3.93 ± 0.20 4.07 ± 0.22
Moderate (> 4 to ≤ 6 mm)
Control 6.93 ± 0.26 5.68 ± 0.32a 5.68 ± 0.34a
Experimental 6.43 ± 0.20 5.52 ± 0.20a 5.71 ± 0.17a
Deep (> 6 mm)
Control 9.10 ± 0.32 7.04 ± 0.32a 6.55 ± 0.44a
Experimental 8.83 ± 0.32 7.50 ± 0.32a 7.24 ± 0.32a
Overall
Control 5.37 ± 0.42 4.87 ± 0.37a 4.78 ± 0.40a
Experimental 5.24 ± 0,44 4.78 ± 0,26a 4.93 ± 0,32
aStatistically significant difference from baseline (Wilcoxon Signed Ranks test, P < 0.05).
bNo statistically significant differences were observed between groups (Mann-Whitney test, P > 0.05).
(0.88 mm for the SRP and 0.94 mm for the UD + DOXY 
group, Wilcoxon Signed Ranks test, P < 0.05). During 
the following observation period (3 to 6 month 
examination) only minor changes were found. No 
statistically  significant  differences  were  observed 
between the two groups at any interval (Mann-Whitney 
test, P > 0.05).
The  PPD  measurements  were  further  analysed  for 
the three different categories of initial pocket depth. 
For  the  shallow  (PPD  ≤  4  mm),  the  moderate 
(> 4 to ≤ 6 mm) and the deep pockets (PPD > 6 mm) 
the results are presented in Table 3. In the deep pockets 
an  additional,  statistically  significant  reduction  was 
observed in PPD between 3 and 6 months in the 
experimental group (Wilcoxon Signed Ranks test, 
P < 0.05, Table 3).
Clinical Attachment Level (CAL)
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Table 5. Mean numbers (x105, Mean ± SEM) of the 3 microorganisms’ species tested in various initial probing pocket depths at different 
examination intervals
Micro-
organisms
Patients 
Groups
Overall Initial PPD > 4 mm
Baseline 3 months 6 months Baseline 3 months 6 months
Pg
Control 7.36±2.29 2.63±0.72a 1.39±0.44a 7.97±0.24 3.04±0.98a 1.68±0.57
Experimental 5.44±1.37 3.28±0.82a 2.49±0.65a 5.97±1.27 2.98±0.81a 3.22±0.89a
Tf
Control 4.20±1.57 0.75±0.28 0.83±0.24 4.39±1.64 0.95±0.42 1.01±0.27
Experimental 4.26±0.83 1.77±0.49 1.22±0.50 4.78±0.96 1.53±0.52 1.81±0.63
Td
Control 3.03±1.54 0.88±0.23 0.74±0.38 2.86±1.48 0.99±0.34 1.01±0.56
Experimental 4.15±0.79 1.75±0.59 1.54±0.43a 4.12±0.82 2.17±0.75 2.27±0.61
aStatistically significant difference from baseline (Wilcoxon Signed Ranks test, P < 0.05).
Pg = Porphyromonas gingivalis; Tf = Tannerella forsythia; Td = Treponema denticola.
Table 6. Frequency distribution (%) of sites depending on various microorganisms species concentration tested at different examination 
intervals
Micro-
organisms
Patients Groups
≤105 >105
Baseline 3 months 6 months Baseline 3 months 6 months
Pg
Control 58.3 74.4 85.4 41 25.6 14.6
Experimental 46.2 71.8 77.1 53.8 28.2 22.9
Tf
Control 61.1 87.5 81.0 38.9 12.5 19.0
Experimental 63.4 85.3 72.3 36.6 14.7 27.7
Td
Control 73.3 89.5 94.0 26.7 10.5 6.0
Experimental 70.8 79.6 75.4 29.2 20.4 24.6
Pg = Porphyromonas gingivalis; Tf = Tannerella forsythia; Td = Treponema denticola.
revealed for both groups at the 3 month examination 
(0.50 mm for the SRP group and 0.46 mm for the 
UD + DOXY group respectively, Wilcoxon Signed Ranks 
test, P < 0.05, Table 4). No major changes were observed 
for both groups at the 6 month examination. Statistically 
significant  differences  between  the  two  groups  were 
not recorded at any interval (Mann-Whitney test, 
P > 0.05). In the SRP group the 6 month result remained 
significantly  better  compared  to  the  baseline  score 
(Wilcoxon Signed Ranks test, P < 0.05), whereas in 
the UD + DOXY group the mean CAL score did not 
demonstrate  a  significant  difference  in  comparison 
with the baseline value (Wilcoxon Signed Ranks test, 
P > 0.05).
A similar analysis as for the PPD measurements was 
made for the CAL measurements as well. The results 
for the shallow, moderate and deep pockets are shown 
in Table  4. The  differences  between  3  and  6  month 
re-examinations and the baseline examination were 
statistically significant for the two groups (Wilcoxon 
Signed Ranks test, P < 0.05), whereas no statistically 
significant,  inter-group  differences  were  observed 
(Mann-Whitney test, P > 0.05).
Microbiological parameters
In total, 594 microbiological samples were analysed. 
The results for all the investigated species and for all 
of the six sites per patient are summarised in Table 5. 
At the 3 month of examination, a numerical decrease 
was  observed  for  all  the  species. This  decrease  was 
statistically  significant  only  for  Porphyromonas 
gingivalis (Wilcoxon Signed Ranks test, P < 0.05). 
At the 6 month re-examination, a statistically 
significant  difference  with  baseline  was  observed  in 
the experimental group for the Treponema denticola 
(Wilcoxon Signed Ranks test, P < 0.05), attributable to a 
further reduction in numbers of this species between the 
re-examinations. No statistically significant differences 
were found between the two groups at any time interval 
(Mann-Whitney test, P > 0.05).
The  frequency  distribution  revealed  an  increase 
in  the  percentage  of  sites  with  less  or  equal  to  105 
microorganisms for Porphyromonas gingivalis, 
Tannerella forsythia and Treponema denticola and 
a subsequent decrease in the percentage of sites with 
more than 105 microorganisms (Table 6).http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm  J Oral Maxillofac Res 2010 (Oct-Dec) | vol. 1 | No 4 | e1 | p.8
(page number not for citation purposes)
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                                Ioannou et al.
The results of further analysis that was performed for 
the sites that had initial PPD > 4 mm, are presented in 
Table 5. A statistically significant decrease was found for 
Porphyromonas gingivalis in both groups at the 3 month 
examination (Wilcoxon Signed Ranks test, P < 0.05). 
No  statistically  significant  differences  were  found 
between the two groups at any time interval (Mann-
Whitney test, P > 0.05).
DISCUSSION
The  findings  of  the  present  study  indicate  that  the 
adjunctive  use  of  doxycycline  failed  to  significantly 
improve the therapeutic outcome of mechanical 
treatment. In a previous study [11], the hand instruments 
were compared to the ultrasonics in the treatment of 
chronic periodontitis, but no difference was found 
between the two treatment modalities. The addition of 
locally delivered doxycycline in the treatment protocol 
of present study did not seem to offer any beneficial 
effect to the patients treated with ultrasonic debridement 
in comparison to the conventional hand instrumentation 
alone.
A marked reduction in every clinical parameter was 
observed for both treatment modalities in this study. 
Overall  a  statistically  significant  mean  reduction  in 
PPD of 0.88 mm and a mean CAL gain of 0.59 mm 
was recorded for the SRP group. The corresponding 
values for the UD + DOXY group were 0.92 mm and 
0.31 mm. The improvement was more pronounced for 
the moderate and the deep pockets. CAL scores at the 
6 month re-examination did not show a statistically 
significant difference compared to baseline scores in the 
experimental group. In the deep pockets an additional, 
statistically significant, reduction was observed in PPD 
between 3 and 6 months. However no statistically 
significant differences were observed between the two 
groups. This could be explained by the fact that the test 
drug was applied to only 4 pre-selected pockets and 
therefore it would be very difficult to provide a true 
clinical benefit as the measurements were performed for 
the whole dentition. 
The question of whether the adjunctive use of locally 
delivered antimicrobials to mechanical treatment offers 
an improved clinical and microbiological outcome over 
SRP alone remains unanswered. A number of studies 
have reported only limited improvement of CAL and 
PPD recordings when comparing the combined treatment 
protocol (SRP plus locally delivered antimicrobials) to 
conventional mechanical treatment alone [17-20].
Generally a PPD reduction of 1 - 1.5 mm in moderate 
pockets (4 - 6 mm of initial PPD) and of 2 - 2.5 mm in 
deeper sites has to be expected after mechanical root 
instrumentation [21-26].  This  occurs  concomitantly 
with a CAL gain of approximately 0.5 mm and 1.5 mm 
in the moderate and the deep pockets respectively. Any 
additional pocket reduction or CAL gain, following the 
administration of the drug, would therefore represent a 
true clinical benefit and hence may reduce the need for 
additional periodontal surgery.
Previously published studies referring on the utilization 
of locally delivered doxycycline polymer focused on 
its effects when used as a monotherapy. Comparable 
efficacy of the 2 treatments in the terms of reduction in 
pocket depth and gain in clinical attachment level was 
reported in two parallel multicenter studies comparing 
the locally delivered doxycycline to the SRP alone 
[2]. In another multicenter study, tetracycline showed 
a small but significant advantage over scaling and root 
planing [27].
Heijl et al. [28] using a split mouth design, observed 
changes in probing depth comparable to this study for 
each treatment. The difference between the responses 
to scaling alone and scaling combined with tetracycline 
fibers were small and not statistically significant. In a 
systematic review [10], the reviewers generally found 
modest differences for PPD favouring the combined 
treatment.  These,  even  when  statistically  significant, 
ranged from 0.1 mm to 0.5 mm, and were of little 
clinical importance. Effects for CAL gains were smaller 
and statistical significance was less common.
In very accurately designed study [29] two different 
approaches were evaluated for the non-surgical 
treatment of moderate periodontal pockets. Traditional 
SRP was compared to ultrasonic debridement followed 
by 8.5% doxycycline hyclate administration in sites 
deeper than 5 mm. At the 3 month examination better 
results regarding PPD and CAL were observed in the 
ultrasonic debridement group than in the SRP group. 
A retreatment of non-responding sites (PPD > 5 mm) 
consisting of ultrasonic debridement combined with 
doxycycline application in the SRP group at this 
time point lead to a similar clinical outcome for both 
groups 6 months after baseline. Taking into account the 
reduced time needed for ultrasonic treatment the authors 
concluded  that  simplified,  subgingival  debridement 
in conjuction with doxycycline application could be a 
justified approach for deeper periodontal pockets.
Although, in the present study the time required for 
the  instrumentation  was  not  specifically  recorded, 
the therapists felt that ultrasonic debridement was 
less  time  consuming  than  hand  instrumentation. The 
patient-centered outcome variables, like reduced 
treatment time, are considered of importance in the 
evaluation  of  treatment  outcome  today.  Simplified, 
less time and effort demanding procedures like 
ultrasonic debridement combined with locally delivered   antimicrobials, i.e. doxycycline hyclate, could represent 
a reliable alternative in treating moderate periodontal 
pockets or can be an option for patients where a surgical 
intervention is not indicated. In this respect the findings 
of the present study are in accordance with those of the 
Wennstrom et al. study [29].
Adjunct use of the locally delivered drugs seems to 
have a beneficial effect in smokers and in retreatment 
of the patients with persisting periodontal pockets. 
The  adjunctive  use  of  locally  delivered  doxycycline 
in smokers may offer some benefit for the active and 
supportive periodontal treatment in both clinical [30,31] 
and  microbiological  findings  [32,33]. Initial studies 
on maintenance patients have shown that the local 
application of tetracyclines seems to offer improved 
results [19-34], although more recent data failed to 
support  those  findings  [35,36]. In accordance with 
that, Tomasi et al. [37] concluded that locally delivered 
doxycycline failed to improve the healing outcome 
following the re-instrumentation with a piezo-ceramic 
ultrasonic device of periodontal pockets with post-
therapeutic depth greater or equal to 5 mm. 
At the 3 month re-examination both therapeutic 
approaches resulted in a statistically significant reduction 
of the number of Porphyromonas gingivalis only. A 
profound,  yet  not  statistically  significant,  reduction 
was observed for Tannerella forsythia and Treponema 
denticola as well, but in no case was eradication of 
the periopathogenic species found. Following the 
administration of drug, an adjunct effect of doxycycline 
on the presence of Treponema denticola was observed 
after 6 months in the experimental group.
In  the  present  study  no  statistically  significant 
differences were observed between the two groups 
regarding the microbiological parameters. The findings 
are in accordance with earlier studies comparing scaling 
and root planing alone with scaling and root planing 
followed by the application of locally delivered drugs in 
initial [38,39] and supportive periodontal treatment [35]. 
In contrast, Goodson et al. [40] in a large, multicenter 
trial showed a greater reduction in the numbers and 
proportions of red complex bacteria following the 
adjunctive use of minocycline microspheres.
In order to be effective antimicrobials must reach 
their target site and be maintained there in sufficient 
concentrations long enough for their antimicrobial 
effect to occur [8].  The  concentration  required  for 
efficacy is often estimated from the minimum inhibitory 
concentration (MIC), although this has substantial 
shortcomings; in particular, the fact that MIC is assessed 
in vitro whereas the drug is active in vivo in a constantly 
changing host environment. Other problems related to 
estimating effective drug concentrations in vivo are the 
large number of periodontal subgingival organisms and 
the large variation in the MICs of isolates [41]. Defining 
the minimally effective concentration is complex and 
most dosages are based on in vitro experiments in which 
bacteria were grown under planktonic conditions. It is 
known that bacteria are organized into biofilms when 
present in the periodontal pocket. These biofilms will 
probably  require  a  significantly  higher  concentration 
of antimicrobial to kill those bacteria where Cargill 
et al. [42] found that legionellae in biofilms were 135 
times more resistant to iodination when compared to 
microorganisms growing in non-organised or planktonic 
fashion [42-44]. This is a strong indication that locally 
delivered antimicrobials should be used adjunctively 
with mechanical instrumentation to disrupt the biofilms.
A concern in the use of antimicrobials in the treatment 
of chronic periodontitis is the risk for the emergence of 
an antibiotic-resistant complex of species. This issue in 
relation to the use of locally applied, sustained-release 
doxycycline was evaluated in a recent study of Walker 
et al. [45]. It was concluded that doxycycline treatment 
did not result in a change of actual number of resistant 
bacteria or in the acquisition of antibiotic resistance.
CONCLUSIONS
According to the findings of present study the adjunctive 
use of locally delivered doxycycline did not seem to add 
any beneficial effect to the active treatment of chronic 
periodontitis. Only in deep pockets an additional 
improvement was observed between 3 and 6 months in 
the experimental group, which however was not strong 
enough to provide a statistically significant difference 
between the two groups. In conclusion, it is suggested 
that more long-term studies focusing on the outcome 
of the combined therapy during supportive periodontal 
treatment are needed, where more favourable results 
could be expected, especially in the case of deep pockets.
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